IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE. FMHR 2026, 4 (3), 4646-4654.